Your browser doesn't support javascript.
loading
Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination.
Ali, Hamad; Alterki, Abdulmohsen; Sindhu, Sardar; Alahmad, Barrak; Hammad, Maha; Al-Sabah, Salman; Alghounaim, Mohammad; Jamal, Mohammad H; Aldei, Ali; Mairza, Mohammad J; Husain, Maitham; Deverajan, Sriraman; Ahmad, Rasheed; Cherian, Preethi; Alkhairi, Irina; Alkandari, Abdullah; Abubaker, Jehad; Abu-Farha, Mohamed; Al-Mulla, Fahd.
Afiliación
  • Ali H; Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center (HSC), Kuwait University, Jabriya, Kuwait.
  • Alterki A; Department of Genetics and Bioinformatics, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Sindhu S; Department of Otolaryngology, Head, and Neck Surgery, Zain and Al-Sabah Hospitals, Ministry of Health, Kuwait City, Kuwait.
  • Alahmad B; Medical Division, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Hammad M; Department of Immunology and Microbiology, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Al-Sabah S; Animal & Imaging Core Facility, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Alghounaim M; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States.
  • Jamal MH; Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Aldei A; COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait City, Kuwait.
  • Mairza MJ; COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait City, Kuwait.
  • Husain M; COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait City, Kuwait.
  • Deverajan S; Rheumatology Unit, Department of Medicine, Amiri Hospital, Kuwait City, Kuwait.
  • Ahmad R; Department of Internal Medicine, Amiri Hospital, Kuwait City, Kuwait.
  • Cherian P; Planning and Follow-Up Department, Ministry of Health, Kuwait City, Kuwait.
  • Alkhairi I; National Dasman Diabetes Biobank, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Alkandari A; Department of Immunology and Microbiology, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Abubaker J; Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Abu-Farha M; Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
  • Al-Mulla F; Department of Genetics and Bioinformatics, Dasman Diabetes Institute (DDI), Dasman, Kuwait.
Front Immunol ; 12: 752233, 2021.
Article en En | MEDLINE | ID: mdl-34899701
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Vacuna BNT162 / Anticuerpos Antivirales Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Vacuna BNT162 / Anticuerpos Antivirales Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article